Tyrosine kinase inhibitor-induced carotid stenosis: A case report

Tyrosine kinase inhibitor-induced carotid stenosis: A case report

Tyrosine kinase inhibitors are considered as highly effective and relatively safe drugs for the treatment of chronic myeloid leukemia. If several side effects on short and long term are well known and described, their involvement in the development of carotid stenosis remains unclear. Here, we descr...

Full description

Bibliographic Details
Main Authors:	Jeanne Hersant, Martine Gardembas, Georges Leftheriotis, Patrick Vandeputte, Pierre Abraham, Samir Henni
Format:	Article
Language:	English
Published:	Elsevier 2019-01-01
Series:	Leukemia Research Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213048919300111

Similar Items

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
by: Miguel Carracedo, PhD, et al.
Published: (2020-03-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
by: Elisabetta Abruzzese, et al.
Published: (2014-04-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
by: Maria Dimou, et al.
Published: (2014-01-01)

Tyrosine kinase inhibitors in hematological malignancies
by: Kamila Kosior, et al.
Published: (2011-12-01)

Synthesis of new tyrosine kinase inhibitors
by: Sørum, Christopher
Published: (2009)

Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
by: Diogo Alpuim Costa, et al.
Published: (2018-05-01)

Tyrosine Kinase Inhibitor Induced Isolated Pericardial Effusion
by: Vineet Agrawal, et al.
Published: (2015-02-01)

Carotid stenosis
by: Johansson, Elias
Published: (2011)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
by: G. V. Lukina, et al.
Published: (2015-12-01)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
by: Evan Pisick, et al.
Published: (2004-01-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
by: Yi-fan Chen, et al.
Published: (2011-12-01)

Tyrosine kinase inhibitors and hypothyroidism – an intriguing link
by: Davor Kust, et al.
Published: (2016-06-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
by: John J. Ryan, MD
Published: (2016-12-01)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
by: Lihua Huang, et al.
Published: (2015-09-01)

Targeting tumour microenvironment by tyrosine kinase inhibitor
by: Hor-Yue Tan, et al.
Published: (2018-02-01)

Second-generation inhibitors of Bruton tyrosine kinase
by: Jingjing Wu, et al.
Published: (2016-09-01)

The synthesis of novel inhibitors of protein tyrosine kinases
by: Munawar, Munawar Ali
Published: (1996)

Design and synthesis of protein tyrosine kinase inhibitors
by: Peng, Shao-Zheng, et al.
Published: (1998)

Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer
by: Nikolaos Dervisis, et al.
Published: (2016-01-01)

Forearm Volume Changes Estimated by Photo-Plethysmography During an Original Candlestick/Prayer Maneuver in Patients With Suspected Thoracic Outlet Syndrome
by: Jeanne Hersant, et al.
Published: (2021-04-01)

Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
by: Natalia I. Moguillansky, MD, et al.
Published: (2017-01-01)

Carotid Artery Stenosis
by: Edward Y Woo, et al.
Published: (2019-01-01)

Modulation of mucin expression in respiratory epithelial cells : effect of ErbB receptor tyrosine kinase inhibitors
by: Nuseibeh, Samir
Published: (2009)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
by: Xu H, et al.
Published: (2019-07-01)

Carotid endarterectomy: The procedure of choice for carotid stenosis
by: B.V. Savitr Sastri, et al.
Published: (2013-01-01)

Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?
by: Avital F. Barak, et al.
Published: (2011-12-01)

Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum
by: Erisa Alia, MD, et al.
Published: (2020-06-01)

Novel Approaches for Efficient Delivery of Tyrosine Kinase Inhibitors
by: Zahra Moradpour, et al.
Published: (2019-01-01)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
by: Ashraf El-Dabh, et al.
Published: (2019-07-01)

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
by: Domenico Ribatti
Published: (2010-04-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
by: D. Samuel Metibemu, et al.
Published: (2019-12-01)

Ponatinib and other CML Tyrosine Kinase Inhibitors in Thrombosis
by: Peng Zeng, et al.
Published: (2020-09-01)

A Review on Newer Tyrosine Kinase Inhibitors and their Uses
by: NITHU M KUMAR, et al.
Published: (2018-08-01)

Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy.
by: Avadhut D Joshi, et al.
Published: (2012-01-01)

Resistant Mechanism and Treatment Strategy of Tyrosine Kinase Inhibitors
by: Jianbing QIAO, et al.
Published: (2011-10-01)

The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance
by: Eliska Ruzickova, et al.
Published: (2019-10-01)

Transport of six tyrosine kinase inhibitors: active or passive?
by: Richard J. Honeywell, et al.
Published: (2016-03-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
by: Qinlian Jiao, et al.
Published: (2018-02-01)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
by: Sachin Gupta, et al.
Published: (2008-10-01)

Environment-moiety relationships for discovering tyrosine kinase inhibitors
by: Hsu, Wei-Tse, et al.
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t02kpd4iaokbjv7jlt75cmoa6q